Trials / Sponsors / COUR Pharmaceutical Development Company, Inc.
COUR Pharmaceutical Development Company, Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 D Type 1 Diabetes Mellitus, T1D, T1DM | Phase 1 / Phase 2 | 2025-05-12 |
| Recruiting | Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis | Phase 1 / Phase 2 | 2024-05-30 |
| Terminated | CNP-201 in Subjects With Peanut Allergy Peanut Allergy | Phase 1 | 2022-03-14 |
| Completed | Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Chol Primary Biliary Cholangitis | Phase 1 / Phase 2 | 2022-01-25 |
| Terminated | Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanu Peanut Allergy | Phase 1 | 2021-06-02 |